Tom Cruise re-ignited the debate about psychiatry–its false claims & drug hazards – Florida Medicaid restricts Fri, 01 Jul 2005 Tom Cruise “kicked off a debate over a subject that a lot of people don’t feel comfortable discussing: whether Americans are too quick to turn to prescription drugs and whether…
Mental Health Tests For Kids Spark Debate – Chicago Tribune Sun, 5 Jun 2005 The Chicago Tribune has woken to the major debate which is underway about a government-sponsored initiative to increase profits for the psychotropic drug industry and its beneficiaries in the mental health provider industry: “The furor started…
AMERICA’S OVERMEDICATED CHILDREN By Vera Sharav YOUTH and MEDICINES in June 1-3, 2005 KILEN: Consumers Institute for Medicines and Health SWEDEN “Forgotten Children” is an investigative report by Carole Keeton Strayhorn,[1] the Texas Comptroller (2004) who uncovered evidence that 60% of children in the Texas foster care system are being…
“Forgotten Children” is an investigative report by Carole Keeton Strayhorn,[1] the Texas Comptroller (2004) who uncovered evidence that 60% of children in the Texas foster care system are being drugged with powerful psychotropic drugs, most of which have not been tested in or approved for use by children. The Food and Drug Administration (FDA) acknowledges that many of these drugs have serious adverse side effects, both physical and psychological. The Comptroller said she was alarmed that in her review of a single month (November 2003), two powerful antipsychotic drugs — Risperdal and Zyprexa — made up half of the drugs prescribed to foster children in Texas. These two drugs have been approved only for adults for the treatment of psychosis – primarily schizophrenia – yet, she found that children as young as four, were receiving these powerful, mind-altering drugs.
UK Parliament Report Re: Pharma Influence / US RegulatorsComatose as 258 Fatal Suicides Linked to Neurontin Wed, 6 Apr 2005 The Health Committee of the British House of Commons, has just released its report, “The Influence of the Pharmaceutical Industry.” This landmark document is not just of value to UK…
Children’s Mental Health in the 108th Congress: The Good, The Bad, and The Ugly Wed, 15 Dec 2004 AHRP board member, Dr. Karen Effrem, provides a succinct overview of actions – the good, the bad, and the ugly–taken by the 108th Congress will have an impact on children’s health and…
Texas Foster Care Investigation – Children as young as 3 are drugged with antipsychotics Sat, 13 Nov 2004 The Dallas Morning News reports that Texas comptroller, Carole Keeton Strayhorn, who hade conducted an investigation of the foster care system, concluded that up to $4 million a year might be wasted…
Complaint to FDA: Pfizer Failed to Disclose Zoloft Suicide Risk in NYT Adverstisement Mon, 1 Nov 2004 ALLIANCE FOR HUMAN RESEARCH PROTECTION (AHRP) Tel. 212-595-8974 142 West End Ave. Suite 28P Fax: 212-595-9086 New York, NY 10023 www.ahrp.org November 1, 2004 Thomas W. Abrams Director Office…
Scientists Decode Secret of Getting NIH Grants – WSJ Mon, 28 Jun 2004 The Secret of Getting Grants: Marketing Helps University Win $350 Million a Year, by Bernard Wysocki, a front page article in The Wall Street Journal, provides insight into an iron triangle that controls medical research. This triumvirate…
Psychiatrist Scolds the APA After Winning Distinguished Fellow Award/ NYC Sues 44 Pharma Companies Fri, 6 Aug 2004 After receiving a 50-year “distinguished fellow award” from the American Psychiatric Association in May, 2004, Alex Braiman, M.D. a practicing psychiatrist, wrote a letter acknowledging that the APA’s “advocacy of unsupported “biologic”…
TIME – Medicating Young Minds with Mood / Behavior Altering Drugs Sat, 1 Nov 2003 A TIME magazine cover story (excerpt below) looks at the inordinate popularity of prescribing mood altering psychotropic drugs for children begins to raise troubling questions about the specter of doing long-term harm to children. Doctors…
Walk-in Drug Trial Clinic NYC Upper East Side Wed, 17 Sep 2003 While ethics is currently a hot topic at universities, and ethics committees and conferences have become a growth industry within the research community, ethics has not affected the increasing commercialization of medicine and clinical trials. Dr. Ronald Fieve,…
